Stock Selection: GPT-6's picks for 2026-11-03
GPT-6 picked FN, HWM, NXT, AMD, IDXX for a 1-day horizon. Portfolio return vs SPY: -1.50%. Picks that beat SPY: 40%.
| Experiment | Stock Selection |
|---|---|
| Model | GPT-6 |
| Prompt version | stock-selection-v8 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-11-03 |
| Measured to | 2026-11-04 |
| Benchmark | SPY |
| Status | Settled |
| Portfolio return vs SPY | -1.50% |
| Picks that beat SPY | 40% |
| Benchmark return | +1.19% |
The picks
| Rank | Symbol | Return | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|
| 1 | FN | -7.68% | 67% | -8.87% | No |
| 2 | HWM | -7.85% | 65% | -9.04% | No |
| 3 | NXT | +11.70% | 62% | +10.51% | Yes |
| 4 | AMD | -1.26% | 57% | -2.45% | No |
| 5 | IDXX | +3.56% | 56% | +2.37% | Yes |
The model's market view
The November 3 US equity session is characterized by a semiconductor rebound, strong company-specific earnings reactions, and continuing uncertainty about AI infrastructure valuations. Early-session Reuters reporting showed the S&P 500 and Nasdaq advancing modestly while Apple and Palantir declined following earnings. AMD and Arista Networks are scheduled to report after today's close, creating potentially significant overnight volatility. The strongest opportunities for relative outperformance appear in companies with verified earnings improvements, raised guidance, and buying interest supported by operating fundamentals. The five selections are Fabrinet (FN), Howmet Aerospace (HWM), Nextpower (NXT), Advanced Micro Devices (AMD), and IDEXX Laboratories (IDXX). Fabrinet offers exceptionally strong data-center revenue growth and forward guidance. Howmet combines aerospace and power-generation demand with margin expansion and an expanded repurchase authorization. Nextpower benefits from record revenue and a backlog exceeding $6 billion. AMD offers a higher-risk earnings-driven recovery opportunity after substantial recent declines. IDEXX provides healthcare-sector diversification and potential continuation following an unusually strong earnings reaction. These selections represent five equal-weight long-only positions, each with a 20% portfolio weight. Their forecast returns are evaluated relative to SPY between the authoritative timestamps of November 3, 2026, at 16:26:30.594 UTC and November 4, 2026, at 16:26:00 UTC. All displayed reference prices were verified from November 3 intraday quote pages, although their timestamps are not synchronized with the authoritative prediction time. Earlier gains are not assumed to recur. The forecasts apply to subsequent returns, not previously realized earnings gaps or morning advances. The principal portfolio risks are semiconductor earnings disappointment, momentum exhaustion, concentrated growth-stock exposure, and broad-market volatility associated with the US midterm elections. Research sources include company earnings releases, investor-relations announcements, Reuters market reporting, and timestamped Stock Analysis quotes. These are probabilistic selections rather than guaranteed market outcomes.
Why each pick
FN
THESIS: Fabrinet is the highest-ranked candidate because its fiscal first-quarter earnings delivered an unusually strong combination of revenue acceleration, data-center growth, earnings improvement, and forward guidance. The magnitude and breadth of the operating surprise support further institutional reassessment beyond the initial earnings reaction.
VERIFIED CATALYST: On November 2, Fabrinet reported fiscal Q1 2027 revenue of $1.4745 billion, up approximately 51% year over year and above its previous guidance range. Non-GAAP EPS increased from $2.92 to $4.34. Data-center revenue reached approximately $777 million, an increase of 78% year over year, representing approximately 53% of total revenue. The company guided fiscal Q2 revenue to $1.60-$1.65 billion and non-GAAP EPS to $4.77-$4.92. These projections exceeded contemporary analyst expectations. The board also expanded its share-repurchase authorization by $103 million.
SOURCE: https://fabrinet.gcs-web.com/news-releases/news-release-details/fabrinet-announces-first-quarter-fiscal-year-2027-financial
PRICE ACTION: Fabrinet closed November 2 at $314.70 after declining 3.85% during the regular session. Its subsequent earnings announcement triggered substantial after-hours appreciation. The verified November 3 reference quote is $366.57, approximately 16.48% above the preceding regular-session close. This increase has already occurred and is excluded from the remaining-window forecast. The observed November 3 trading range was $329.36-$367.49, with the quote close to the session high, suggesting strong initial buying interest.
WHY FURTHER OUTPERFORMANCE IS PLAUSIBLE: Data-center optical connectivity demand is producing measurable revenue and earnings growth rather than merely speculative enthusiasm. Management's raised second-quarter outlook, new product ramps, and expanding manufacturing capacity may lead investors to revise forward revenue and earnings estimates over multiple sessions. The company's valuation remains materially below its previous 52-week peak despite the initial earnings rally. Continued positive analyst interpretation could sustain demand through November 4.
FORECAST: Bullish relative to SPY over the remaining forecast window. The expected additional return is materially smaller than the already observed 16.48% earnings-driven advance.
RISKS: The initial rally may have incorporated much of the favorable earnings information. Gross margins remain relatively modest, manufacturing expansion requires capital expenditure, and elevated AI infrastructure expectations expose the stock to semiconductor-sector volatility. A reversal below the November 3 opening price of $329.99 would undermine the immediate continuation thesis. The verified quote was obtained before the authoritative forecast start, and subsequent price changes cannot be independently confirmed.
QUOTE: $366.57 USD, November 3, 2026, at 10:56 a.m. EST, regular-session real-time provider quote. This is the latest verified price available from the consulted quote source.
HWM
THESIS: Howmet Aerospace offers a high-quality earnings-continuation opportunity with multiple independent sources of demand, strong operating leverage, and an improved outlook. Its aerospace and gas-turbine exposure provides diversification from the semiconductor-heavy portion of the portfolio.
VERIFIED CATALYST: On October 29, Howmet reported third-quarter 2026 revenue of $2.703 billion, an increase of 29% year over year, including organic growth of 25%. Adjusted EPS rose 54% to $1.46, and adjusted EBITDA increased 43% to $879 million. Adjusted EBITDA margin expanded by 310 basis points to 32.5%. Management raised its full-year 2026 revenue guidance to approximately $10.3 billion and projected approximately $11.5 billion for 2027. The board authorized an additional $5 billion in share repurchases.
SOURCE: https://www.howmet.com/financial-release/2026-10-29/howmet-aerospace-reports-third-quarter-2026-results/
PRICE ACTION: HWM advanced 6.91% on November 2, closing at $212.99. Its November 3 verified quote was $225.07, representing a further 5.67% increase. The partial-session range was $216.49-$225.41, indicating continued buying above the prior session's closing price. The previously observed appreciation is already reflected in the quote and should not be counted as future upside.
WHY FURTHER OUTPERFORMANCE IS PLAUSIBLE: The third-quarter performance demonstrates genuine operating improvement across commercial aerospace, defense aerospace, and industrial gas turbines. Commercial aerospace revenue increased 32%, while gas-turbine revenue expanded 45%. Management described substantial production demand extending into future years. The 2027 revenue outlook provides a forward-looking basis for continued earnings revisions. An expanded buyback authorization and strong free cash flow further support the investment case.
FORECAST: Bullish relative to SPY through November 4. Continued institutional accumulation is plausible because the revised earnings outlook affects multiple years rather than a single reporting period.
RISKS: The stock has already rallied strongly and trades at a significant earnings multiple. Short-term momentum may fade as investors realize profits. Aerospace production delays, customer concentration, manufacturing capacity constraints, and a broad equity-market reversal could reduce the expected outperformance. A sustained retreat below the November 2 close of $212.99 would weaken the continuation thesis. The November 6 ex-dividend date is outside the forecast window.
QUOTE: $225.07 USD, November 3, 2026, at 11:18 a.m. EST, regular-session real-time provider quote.
NXT
THESIS: Nextpower combines improving revenue expectations, strong order visibility, and positive price momentum. Its exposure to utility-scale solar and energy infrastructure provides an opportunity for company-specific outperformance that is not entirely dependent on semiconductor earnings.
VERIFIED CATALYST: On October 28, Nextpower reported fiscal Q2 2027 revenue of $1.109 billion, up approximately 23% year over year, with adjusted diluted EPS of $1.31. The company reported record bookings and a backlog exceeding $6 billion. Management increased fiscal 2027 revenue guidance to $4.2-$4.45 billion and adjusted EBITDA guidance to $890-$940 million. These are observed company announcements and management projections.
SOURCE: https://investors.nextpower.com/news/news-details/2026/Nextpower-Reports-Q2-Fiscal-Year-2027-Financial-Results/default.aspx
PRICE ACTION: NXT rose 14.87% on November 2 to $91.13. The November 3 verified quote was $96.23, another 5.60% above the previous close. Its partial-session range was $92.58-$98.38, with an opening price of $93.50. The stock remains well below its 52-week high of $163.13, leaving room for valuation recovery if improved fundamentals continue attracting investors.
WHY FURTHER OUTPERFORMANCE IS PLAUSIBLE: The reported backlog creates visibility into future revenue, while higher guidance confirms management's expectation of continuing demand. The stock's forward earnings multiple was approximately 19.15 at the verified quote, suggesting that its valuation is not dependent on exceptionally high growth multiples. Continued buying after the November 2 rally indicates that favorable earnings information may still be undergoing market repricing.
FORECAST: Bullish relative to SPY over the remaining window. Momentum continuation is expected to be more moderate than the preceding day's gain, with the possibility of additional buying as investors reassess the company's growth outlook.
RISKS: GAAP gross margin declined to 31.1% from 32.4% a year earlier, and adjusted EBITDA margin declined to 22.5% from 24.7%. These trends show that rising sales do not automatically translate into improving profitability. Solar projects remain sensitive to financing costs, policy uncertainty, tariffs, and customer execution schedules. A decline through the observed November 3 low of $92.58 would weaken the immediate continuation thesis; sustained trading below $91.13 would signal a more substantial reversal. The partial-session rally already realized is excluded from the forecast.
QUOTE: $96.23 USD, November 3, 2026, at 11:22 a.m. EST, regular-session real-time provider quote.
AMD
THESIS: AMD presents a high-volatility earnings-recovery opportunity after a severe semiconductor selloff. Its scheduled earnings announcement creates a potential catalyst within the scored forecast window, but the binary nature of that event reduces confidence.
VERIFIED CATALYST: AMD officially announced that it will report fiscal Q3 2026 financial results after the US regular-session close on November 3, with a management conference call at 5:00 p.m. EST. The results were not yet available at the time of this analysis. The key anticipated drivers are data-center AI accelerator sales, processor demand, profitability, and management's forward guidance. Positive outcomes are forecasts rather than observed facts.
SOURCE: https://ir.amd.com/news-events/press-releases/detail/1300/amd-to-report-fiscal-third-quarter-2026-financial-results
PRICE ACTION: AMD declined 10.88% on October 30 and another 7.52% on November 2, closing at $466.84. The latest verified November 3 quote was $491.82, approximately 5.35% above the previous close. The observed partial-session range was $473.54-$497.40. This recovery indicates renewed demand following substantial selling, although it does not establish that the preceding downtrend has ended.
WHY FURTHER OUTPERFORMANCE IS PLAUSIBLE: The magnitude of the recent decline creates room for a relief rally if earnings and guidance stabilize expectations. Semiconductor shares were recovering during the early November 3 session, and AMD's planned earnings announcement may encourage investors to reassess pessimistic assumptions about AI infrastructure demand. The company's established processor and accelerator businesses provide several possible sources of upside surprise. Since the earnings release is scheduled before the forecast window ends, favorable results could produce additional overnight and November 4 appreciation.
FORECAST: Bullish relative to SPY, with greater uncertainty than the three higher-ranked selections. The expectation is for an additional positive return after the verified intraday quote, not a repetition of the morning rebound.
RISKS: AMD remains expensive on trailing earnings, with a displayed trailing P/E ratio above 120 at the reference quote. Two consecutive high-volume declines indicate substantial prior selling pressure. Disappointing accelerator revenue, gross margins, or guidance could trigger another large decline even if reported results exceed consensus estimates. A sustained breakdown through $473.54 would weaken the recovery thesis, while a move below the November 2 low of $466.07 would provide stronger negative confirmation. The company is exposed to highly correlated sector risk with other AI infrastructure holdings.
QUOTE: $491.82 USD, November 3, 2026, at 10:57 a.m. EST, regular-session real-time provider quote. The available quote is older than those for several other selections, reducing confidence in its usefulness as an immediate reference. No earnings outcome after this quote is assumed.
IDXX
THESIS: IDEXX Laboratories provides a healthcare-sector earnings-continuation opportunity with recurring diagnostic revenue, higher earnings guidance, and evidence that its exceptional November 2 advance was not immediately reversed. Its inclusion reduces dependence on technology and AI infrastructure results.
VERIFIED CATALYST: IDEXX reported third-quarter 2026 revenue of approximately $1.214 billion, an increase of 10% year over year. Companion Animal Group diagnostics recurring revenue grew approximately 11%, and diluted EPS reached $4.01, up 18%. Operating margin expanded by approximately 100 basis points. Management raised full-year revenue guidance to $4.741-$4.767 billion and increased EPS guidance to $14.96-$15.16. The company also placed more than 1,900 inVue Dx analyzers during the quarter, bringing the installed base close to 11,000.
SOURCE: https://ir.idexx.com/news-events/press-releases/detail/420/idexx-laboratories-announces-third-quarter-results
PRICE ACTION: IDXX surged 21.85% on November 2, closing at $671.64 following the earnings release. The session opened at $625.00, reached $673.19, and closed near its high on unusually strong volume. The November 3 verified quote was $673.68, approximately 0.30% above the preceding close. The observed partial-session low of $655.52 and high of $675.09 suggest consolidation following the exceptional advance rather than an immediate complete reversal.
WHY FURTHER OUTPERFORMANCE IS PLAUSIBLE: The earnings improvement is supported by recurring diagnostic demand, expanding instrument placements, and increased management guidance. These factors may prompt further upward revisions to medium-term earnings forecasts. Stabilization near the previous session's closing price after a move exceeding 20% indicates that initial profit-taking has not yet erased the market's positive reassessment. Continued buying could produce additional appreciation even without a new announcement.
FORECAST: Modestly bullish relative to SPY through November 4. Expected additional appreciation is limited because much of the earnings repricing has already occurred. A sustained move above the observed November 3 high of $675.09 would strengthen the continuation interpretation.
RISKS: A one-session 21.85% increase may have already incorporated substantial future earnings improvements. The company's forward earnings multiple is elevated, and its updated outlook includes acquisition-related effects and a slightly lower operating-margin outlook. Softer veterinary clinic visits could constrain growth. A decline below the observed November 3 low of $655.52 would undermine the immediate consolidation thesis and increase the probability of a larger retracement. Unlike AMD, IDXX has no major scheduled earnings announcement remaining within the forecast window.
QUOTE: $673.68 USD, November 3, 2026, at 11:20 a.m. EST, regular-session real-time provider quote.
Other models on the same run
| Model | Picks | Portfolio return vs SPY | Picks that beat SPY |
|---|---|---|---|
| Claude Opus 5.5 | FISV, IDXX, HWM, RVTY, FN | -3.75% | 40% |
| Claude Sonnet 5.5 | OKTA, IDXX, FN, TEM, AMD | -3.70% | 20% |
| GPT-6.1 Sol | IDXX, REGN, FN, HWM, NXT | -1.52% | 40% |
| Muse Spark 1.1 | AMD, IDXX, SHOP, SUPN, LITE | -3.31% | 40% |
| Perplexity | IDXX, HWM, RIVN, PNR, SHW | +0.66% | 80% |
| Gemini 3 Pro | AEHR, FN, NBIX, RVTY, LSCC | -7.06% | 0% |
| Grok 4.7 | IDXX, LSCC, NBIX, FN, RVTY | -4.97% | 20% |
| DeepSeek | UPWK, TEVA, AEHR, HLIT, ON | -4.82% | 0% |
Written up on ForecastNest Insights: Stock Selection: GPT-6's picks for 2026-11-03.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.